UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I trial of taxol given by a 6-hour intravenous infusion

Journal of clinical oncology, 1991-07, Vol.9 (7), p.1261-1267

1991

Volltextzugriff (PDF)

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2889-2895

2003

Volltextzugriff (PDF)

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2003-09, Vol.14 (9), p.1399-1405

2003

Volltextzugriff (PDF)

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects

Journal of clinical oncology, 1989-08, Vol.7 (8), p.1093-1098

1989

Volltextzugriff (PDF)

Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4114-4114

2010

Volltextzugriff (PDF)

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

The American journal of clinical nutrition, 1997-05, Vol.65 (5), p.1495-1501

1997

Volltextzugriff (PDF)

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

European journal of cancer (1990), 1994, Vol.30 (3), p.417-418

1994

Volltextzugriff (PDF)

Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.68-72

1999

Volltextzugriff (PDF)

Etoposide in gastric cancer

Seminars in oncology, 1992-12, Vol.19 (6), p.59-62

1992

Volltextzugriff (PDF)

Phase I clinical investigation of amonafide

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1351-1358

1989

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic trial of flavone acetic acid

JNCI : Journal of the National Cancer Institute, 1991-01, Vol.83 (2), p.124-128

1991

Volltextzugriff (PDF)

Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8500-8500

2006

Volltextzugriff (PDF)

A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (navelbine) : study design and goals

Seminars in oncology, 1995-04, Vol.22 (2), p.38-40

HAVLIN, K

1995

Volltextzugriff (PDF)

Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8124-8124

2005

Volltextzugriff (PDF)

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study

Anti-cancer drugs, 1995-04, Vol.6 (2), p.229-236

1995

Volltextzugriff (PDF)

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (23), p.7496-7500

1990

Volltextzugriff (PDF)

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8023-8023

2004

Volltextzugriff (PDF)

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8023-8023

2004

Volltextzugriff (PDF)

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule

Anti-cancer drugs, 1994-04, Vol.5 (2), p.151-159

1994

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic trial of hepsulfam

Cancer research (Chicago, Ill.), 1991-12, Vol.51 (23), p.6268-6272

1991

Volltextzugriff (PDF)

Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators

Anti-cancer drugs, 1991-08, Vol.2 (4), p.357

1991

Volltextzugriff (PDF)

Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer

Cancer treatment and research, 1988, Vol.39, p.83

1988

Volltextzugriff (PDF)

A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia

Anti-cancer drugs, 1993-04, Vol.4 (2), p.163

1993

Volltextzugriff (PDF)

High‐dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

Cancer, 1989-02, Vol.63 (3), p.423-427

1989

Volltextzugriff (PDF)

New anticancer agents

Cancer chemotherapy and biological response modifiers, 1991, Vol.12, p.111

1991

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Humans
(70)
Physical Sciences
(70)
Physics
(58)
Life Sciences & Biomedicine
(52)
Biological And Medical Sciences
(35)
Physics, Multidisciplinary
(35)
Female
(32)
Male
(29)
Middle Aged
(25)
Space Life Sciences
(25)
Adult
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)
Aged
(18)
Exact Sciences And Technology
(18)
Oncology
(18)
Fractals
(16)
Life Sciences
(16)
Physics, Mathematical
(16)
Animals
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase I trial of taxol given by a 6-hour intravenous infusion

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects

Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer

Etoposide in gastric cancer

Phase I clinical investigation of amonafide

Phase I clinical and pharmacokinetic trial of flavone acetic acid

Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis

A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (navelbine) : study design and goals

Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule

A phase I clinical and pharmacokinetic trial of hepsulfam

Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators

Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer

A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia

High‐dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

New anticancer agents

Suchergebnisse filtern